Who owns INOVIO PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of INO from SEC Form 13F filings across 82 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 82 institutions disclosed 25.2M shares of INOVIO PHARMACEUTICALS, INC. worth $27.6M — about 30.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
82
13F holders
$27.6M
value, 2026 filers
30.9%
of shares outstanding (25.2M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of INO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.5M | $9.3M | 0.0% | 10.4% | -9.5% |
| 2 | Jupiter Topco LLCNEW | 5.2M | $5.7M | 0.0% | 6.3% | new |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | $4.0M | 0.0% | 4.5% | -37.1% |
| 4 | D. E. Shaw & Co., Inc. | 1.4M | $1.5M | 0.0% | 1.7% | -38.9% |
| 5 | TWO SIGMA INVESTMENTS, LP | 1.2M | $1.4M | 0.0% | 1.5% | +217.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 802,751 | $883,749 | 0.0% | 1% | +0.2% |
| 7 | MILLENNIUM MANAGEMENT LLC | 796,107 | $875,718 | 0.0% | 1% | -43.6% |
| 8 | BlackRock, Inc. | 779,057 | $856,963 | 0.0% | 1% | +17.7% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 480,769 | $528,846 | 0.0% | 0.6% | +22.6% |
| 10 | Caption Management, LLCNEW | 478,950 | $526,845 | 0.0% | 0.6% | new |
| 11 | UBS Group AG | 262,320 | $288,552 | 0.0% | 0.3% | +5.1% |
| 12 | CITADEL ADVISORS LLC | 241,775 | $265,952 | 0.0% | 0.3% | -15.6% |
| 13 | NORTHERN TRUST CORP | 174,394 | $191,833 | 0.0% | 0.2% | -41.6% |
| 14 | NOMURA HOLDINGS INCNEW | 150,000 | $165,000 | 0.0% | 0.2% | new |
| 15 | HRT FINANCIAL LP | 140,432 | $154 | 0.0% | 0.2% | +987.2% |
| 16 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainNEW | 133,648 | $147,012 | 0.0% | 0.2% | new |
| 17 | GMT Capital Corp | 126,119 | $138,731 | 0.0% | 0.2% | 0.0% |
| 18 | JANE STREET GROUP, LLC | 124,525 | $136,977 | 0.0% | 0.2% | +305.7% |
| 19 | GOLDMAN SACHS GROUP INC | 93,720 | $103,092 | 0.0% | 0.1% | +109.6% |
| 20 | Invesco Ltd.NEW | 80,338 | $88,372 | 0.0% | 0.1% | new |
| 21 | Green Alpha Advisors, LLC | 68,055 | $74,861 | 0.1% | 0.1% | +3.8% |
| 22 | MORGAN STANLEY | 50,256 | $55,283 | 0.0% | 0.1% | -21.3% |
| 23 | RAYMOND JAMES FINANCIAL INC | 42,286 | $46,515 | 0.0% | 0.1% | +155.6% |
| 24 | Squarepoint Ops LLC | 36,391 | $40,030 | 0.0% | 0% | +46.5% |
| 25 | Engineers Gate Manager LPNEW | 33,691 | $37,060 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.